Form 13F-HR Novo Holdings A/S For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 3/29/2024
May 17, 2021 7:03 AM EDT
The Securities and Exchange Commission has not necessarily reviewed
the information in this filing and has not determined if it is
accurate and complete.
The reader should not assume that the information is accurate
and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F
FORM 13F COVER PAGE
|
OMB APPROVAL |
OMB Number: |
3235-0006 |
Expires: |
July 31, 2015 |
Estimated average burden |
hours per response: |
23.8 |
|
|
Report for the Calendar Year or Quarter Ended: |
03-31-2021 |
Check here if Amendment |
|
Amendment Number: |
|
This Amendment (Check only one.): |
|
is a restatement. |
|
|
adds new holdings entries. |
Institutional Investment Manager Filing
this Report: |
Name: |
Novo Holdings A/S |
Address: |
TUBORG HAVNEVEJ 19 |
|
|
|
HELLERUP
,
G72900
|
Form 13F File Number: |
028-16231 |
The institutional investment manager filing this report and
the person by whom it is signed hereby represent that the person
signing the report is authorized to submit it, that all information
contained herein is true, correct and complete, and that it is
understood that all required items, statements, schedules, lists, and
tables, are considered integral parts of this form.
Person Signing this Report on Behalf of
Reporting Manager: |
Name: |
Peter Haahr |
Title: |
Chief Financial Officer |
Phone: |
45 3527 6500 |
Signature, Place, and Date of Signing: |
/s/ Peter Haahr |
Hellerup
,
G7
|
05-17-2021 |
[Signature] |
[City, State] |
[Date] |
|
Report Type (Check only one.): |
X |
13F HOLDINGS REPORT. (Check here if all holdings of
this reporting manager are reported in this report.) |
|
13F NOTICE. (Check here if no holdings reported are in
this report, and all holdings are reported by other reporting
manager(s).) |
|
13F COMBINATION REPORT. (Check here if a portion of
the holdings for this reporting manager are reported in this
report and a portion are reported by other reporting manager(s).) |
Form 13F Summary Page |
|
Report Summary: |
|
Number of Other Included
Managers: |
0 |
|
|
|
Form 13F Information Table Entry Total: |
51 |
|
Form 13F Information Table Value Total: |
2,421,558 |
|
(thousands) |
|
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
|
|
|
Form 13F File Number |
Name |
List of Other Included
Managers: |
Provide a numbered list of the name(s) and Form 13F file number(s)
of all institutional investment managers with respect to which this
report is filed, other than the
manager filing this report.
|
[If there are no entries in this list, state “NONE” and omit the
column headings and list entries.]
|
|
No. |
Form 13F File Number |
Name |
The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
The reader should not assume that the information is
accurate and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F
FORM 13F INFORMATION TABLE
|
OMB APPROVAL |
OMB Number: |
3235-0006 |
Expires: |
July 31, 2015 |
Estimated average
burden |
hours per response:
|
23.8 |
|
|
COLUMN 1 |
COLUMN 2 |
COLUMN 3 |
COLUMN 4 |
COLUMN 5 |
COLUMN 6 |
COLUMN 7 |
COLUMN 8 |
|
|
|
VALUE |
SHRS OR |
SH/ |
PUT/ |
INVESTMENT |
OTHER |
VOTING AUTHORITY |
NAME OF ISSUER |
TITLE OF CLASS |
CUSIP |
(x$1000) |
PRN AMT |
PRN |
CALL |
DISCRETION |
MANAGER |
SOLE |
SHARED |
NONE |
ACUTUS MED INC |
COM |
005111109 |
3,409 |
255,000 |
SH |
|
SOLE |
|
255,000 |
0 |
0 |
AERIE PHARMACEUTICALS INC |
COM |
00771V108 |
14,089 |
788,410 |
SH |
|
SOLE |
|
788,410 |
0 |
0 |
AKOUOS INC |
COM |
00973J101 |
6,370 |
459,290 |
SH |
|
SOLE |
|
459,290 |
0 |
0 |
ALIBABA GROUP HLDG LTD |
SPONSORED ADS |
01609W102 |
48,708 |
214,827 |
SH |
|
SOLE |
|
214,827 |
0 |
0 |
ALIGOS THERAPEUTICS INC |
COM |
01626L105 |
59,455 |
2,614,563 |
SH |
|
SOLE |
|
2,614,563 |
0 |
0 |
AMICUS THERAPEUTICS INC |
COM |
03152W109 |
19,393 |
1,962,880 |
SH |
|
SOLE |
|
1,962,880 |
0 |
0 |
APPLE INC |
COM |
037833100 |
126,719 |
1,037,404 |
SH |
|
SOLE |
|
1,037,404 |
0 |
0 |
BIOHAVEN PHARMACTL HLDG CO L |
COM |
G11196105 |
8,769 |
128,300 |
SH |
|
SOLE |
|
128,300 |
0 |
0 |
BLUEPRINT MEDICINES CORP |
COM |
09627Y109 |
19,154 |
197,000 |
SH |
|
SOLE |
|
197,000 |
0 |
0 |
BOLT BIOTHERAPEUTICS INC |
COM |
097702104 |
148,226 |
4,503,991 |
SH |
|
SOLE |
|
4,503,991 |
0 |
0 |
BROOKFIELD ASSET MGMT INC |
CL A LTD VT SH |
112585104 |
136,658 |
3,070,957 |
SH |
|
SOLE |
|
3,070,957 |
0 |
0 |
CABLE ONE INC |
COM |
12685J105 |
86,556 |
47,341 |
SH |
|
SOLE |
|
47,341 |
0 |
0 |
CHECKMATE PHARMACEUTICALS IN |
COM |
162818108 |
26,345 |
2,170,100 |
SH |
|
SOLE |
|
2,170,100 |
0 |
0 |
CONSTELLATION PHARMCETICLS I |
COM |
210373106 |
16,359 |
699,415 |
SH |
|
SOLE |
|
699,415 |
0 |
0 |
CRINETICS PHARMACEUTICALS IN |
COM |
22663K107 |
4,147 |
271,378 |
SH |
|
SOLE |
|
271,378 |
0 |
0 |
EARGO INC |
COM |
270087109 |
36,817 |
737,071 |
SH |
|
SOLE |
|
737,071 |
0 |
0 |
EDGEWISE THERAPEUTICS INC |
COM |
28036F105 |
181,584 |
5,587,207 |
SH |
|
SOLE |
|
5,587,207 |
0 |
0 |
F-STAR THERAPEUTICS INC |
COM |
30315R107 |
377 |
34,819 |
SH |
|
SOLE |
|
34,819 |
0 |
0 |
FLEXION THERAPEUTICS INC |
COM |
33938J106 |
12,560 |
1,403,370 |
SH |
|
SOLE |
|
1,403,370 |
0 |
0 |
FREELINE THERAPEUTICS HLDGS |
SPONSORED ADS |
35655L107 |
29,043 |
2,361,229 |
SH |
|
SOLE |
|
2,361,229 |
0 |
0 |
GALECTO INC |
COM |
36322Q107 |
15,162 |
2,497,791 |
SH |
|
SOLE |
|
2,497,791 |
0 |
0 |
GALERA THERAPEUTICS INC |
COM |
36338D108 |
21,689 |
2,459,021 |
SH |
|
SOLE |
|
2,459,021 |
0 |
0 |
GRAYBUG VISION INC |
COM SHS |
38942Q103 |
1,164 |
209,748 |
SH |
|
SOLE |
|
209,748 |
0 |
0 |
GRITSTONE ONCOLOGY INC |
COM |
39868T105 |
2,626 |
278,478 |
SH |
|
SOLE |
|
278,478 |
0 |
0 |
HARMONY BIOSCIENCES HLDGS IN |
COM |
413197104 |
110,234 |
3,336,378 |
SH |
|
SOLE |
|
3,336,378 |
0 |
0 |
INARI MED INC |
COM |
45332Y109 |
7,727 |
72,212 |
SH |
|
SOLE |
|
72,212 |
0 |
0 |
INOGEN INC |
COM |
45780L104 |
144,919 |
2,759,320 |
SH |
|
SOLE |
|
2,759,320 |
0 |
0 |
INSMED INC |
COM PAR $.01 |
457669307 |
15,553 |
456,631 |
SH |
|
SOLE |
|
456,631 |
0 |
0 |
INSPIRE MED SYS INC |
COM |
457730109 |
8,280 |
40,000 |
SH |
|
SOLE |
|
40,000 |
0 |
0 |
INTERSECT ENT INC |
COM |
46071F103 |
10,626 |
508,922 |
SH |
|
SOLE |
|
508,922 |
0 |
0 |
INOZYME PHARMA INC |
COM |
45790W108 |
38,994 |
1,969,379 |
SH |
|
SOLE |
|
1,969,379 |
0 |
0 |
IOVANCE BIOTHERAPEUTICS INC |
COM |
462260100 |
14,621 |
461,811 |
SH |
|
SOLE |
|
461,811 |
0 |
0 |
KINNATE BIOPHARMA INC |
COM |
49705R105 |
9,348 |
300,000 |
SH |
|
SOLE |
|
300,000 |
0 |
0 |
LAVA THERAPEUTICS NV |
SHS |
N51517105 |
50,542 |
3,327,312 |
SH |
|
SOLE |
|
3,327,312 |
0 |
0 |
LEGEND BIOTECH CORP |
SPONSORED ADS |
52490G102 |
7,376 |
254,176 |
SH |
|
SOLE |
|
254,176 |
0 |
0 |
MILESTONE PHARMACEUTICALS IN |
COM |
59935V107 |
14,652 |
2,530,585 |
SH |
|
SOLE |
|
2,530,585 |
0 |
0 |
MIRUM PHARMACEUTICALS INC |
COM |
604749101 |
48,463 |
2,445,147 |
SH |
|
SOLE |
|
2,445,147 |
0 |
0 |
MORPHIC HLDG INC |
COM |
61775R105 |
167,404 |
2,645,446 |
SH |
|
SOLE |
|
2,645,446 |
0 |
0 |
NKARTA INC |
COM |
65487U108 |
91,918 |
2,793,864 |
SH |
|
SOLE |
|
2,793,864 |
0 |
0 |
PHARVARIS N V |
COM |
N69605108 |
1,399 |
50,000 |
SH |
|
SOLE |
|
50,000 |
0 |
0 |
PRAXIS PRECISION MEDICINES I |
COM |
74006W108 |
80,003 |
2,442,080 |
SH |
|
SOLE |
|
2,442,080 |
0 |
0 |
PROTAGONIST THERAPEUTICS INC |
COM |
74366E102 |
22,474 |
867,724 |
SH |
|
SOLE |
|
867,724 |
0 |
0 |
PULMONX CORP |
COM |
745848101 |
8,556 |
187,047 |
SH |
|
SOLE |
|
187,047 |
0 |
0 |
SEASPINE HLDGS CORP |
COM |
81255T108 |
22,986 |
1,321,006 |
SH |
|
SOLE |
|
1,321,006 |
0 |
0 |
SILK RD MED INC |
COM |
82710M100 |
7,474 |
147,557 |
SH |
|
SOLE |
|
147,557 |
0 |
0 |
SPERO THERAPEUTICS INC |
COM |
84833T103 |
6,902 |
468,902 |
SH |
|
SOLE |
|
468,902 |
0 |
0 |
SPRUCE BIOSCIENCES INC |
COM |
85209E109 |
82,823 |
4,989,336 |
SH |
|
SOLE |
|
4,989,336 |
0 |
0 |
VANGUARD INDEX FDS |
TOTAL STK MKT |
922908769 |
399,718 |
1,933,900 |
SH |
|
SOLE |
|
1,933,900 |
0 |
0 |
VAXCYTE INC |
COM |
92243G108 |
8,235 |
416,937 |
SH |
|
SOLE |
|
416,937 |
0 |
0 |
VERONA PHARMA PLC |
SPONSORED ADS |
925050106 |
7,009 |
838,360 |
SH |
|
SOLE |
|
838,360 |
0 |
0 |
ZOGENIX INC |
COM NEW |
98978L204 |
7,943 |
406,915 |
SH |
|
SOLE |
|
406,915 |
0 |
0 |